The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.175
Bid: 1.15
Ask: 1.20
Change: 0.00 (0.00%)
Spread: 0.05 (4.348%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.175
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects

25 Oct 2019 12:56

Hardman & Co Research Hardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects 25-Oct-2019 / 12:56 GMT/BST


Hardman & Co Research: Recent major contract wins transform prospects

ST's results, announced 9 September, were in line with expectations. Since then, ST has secured a further £0.4m revenue, prompting us to upgrade FY19 PBT estimates by £0.25m. Historical results do not reflect a series of substantial new contracts won, post May 2019 year-end, which have transformed the company. It now has multi-year, multi-million, recurring income contracts from Europeanbased global OEMs. Revenue from one commences October 2021, with start of production (SOP) for the other towards the end of calendar 2021. These will support EBITDA-positive (post-tax credit) for 2020 and profitability in 2022. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/recent-major-contract-wins-transform-prospects/

 

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contacts:

Mike Foster 

+44 20 20 7451 7050

 

mf@hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

897473 25-Oct-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th May 20197:00 amRNSDirector/PDMR Shareholding
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
7th May 20197:00 amRNSTrading Update
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20195:05 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNS£1.9 million placing
26th Feb 20197:00 amRNSInterim Results
11th Dec 20185:36 pmRNSResult of AGM
6th Dec 20187:00 amRNSExercise of Options and Director Dealing
5th Dec 20187:00 amRNSGrant of Options
4th Dec 20187:00 amRNSTrading & Operational Update
17th Sep 20187:00 amRNSPreliminary Results and Notice of AGM
10th Sep 20187:00 amRNSBoard appointment
4th Jul 20183:19 pmRNSGrant of options
3rd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20188:38 amRNS£1.5 Million Placing
13th Jun 20187:00 amRNSPre Close Trading, Customer and Operations Update
10th May 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSHalf-year Report
4th Jan 20187:00 amRNSGrant of Options
2nd Jan 201812:05 pmRNSAppointment of new Financial Director
28th Nov 20172:18 pmRNSResult of AGM
20th Nov 20177:00 amRNSTrading and Operations Update
20th Sep 201712:07 pmRNSHolding(s) in Company
20th Sep 20179:34 amRNSGrant of Options
19th Sep 20177:00 amRNSPreliminary Results and Notice of AGM
9th Aug 20173:47 pmRNSResult of Open Offer Excess
27th Jul 20174:29 pmRNSHolding(s) in Company
26th Jul 201711:21 amRNSOpen Offer Excess
25th Jul 201711:51 amRNSResult of General Meeting
25th Jul 201711:13 amRNSResult of Open Offer
6th Jul 20173:00 pmRNSDirector/PDMR Shareholding
6th Jul 201712:09 pmRNSResult of Placing
6th Jul 201711:45 amRNSResult of Placing
6th Jul 20177:00 amRNSProposed Placing and Open Offer
20th Jun 20177:01 amRNSInvestors Open Day
20th Jun 20177:00 amRNSOperations, Customer and Pre Close Trading Update
18th Apr 20174:56 pmRNSExercise of Options
16th Mar 20178:20 amRNSExercise of Options
13th Feb 20177:00 amRNSHalf Yearly Results
2nd Feb 20177:00 amRNSTrading Update
6th Jan 20173:49 pmRNSChange of Registered Office
8th Dec 20167:00 amRNSTrading Update
29th Nov 20161:14 pmRNSResult of AGM
18th Oct 20164:14 pmRNSHolding(s) in Company
10th Oct 20167:00 amRNSPreliminary Results and Trading Statement
3rd Oct 20167:00 amRNSExercise of Options
5th Sep 20167:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.